- Home
- TBRG vs ME Comparison
TBRG vs ME Comparison
Compare TBRG & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBRG
- ME
- Stock Information
- Founded
- TBRG 1979
- ME 2006
- Country
- TBRG United States
- ME United States
- Employees
- TBRG N/A
- ME N/A
- Industry
- TBRG
- ME Precision Instruments
- Sector
- TBRG
- ME Health Care
- Exchange
- TBRG NYSE
- ME Nasdaq
- Market Cap
- TBRG 186.6M
- ME 168.9M
- IPO Year
- TBRG N/A
- ME N/A
- Fundamental
- Price
- TBRG $12.15
- ME $0.30
- Analyst Decision
- TBRG Buy
- ME Hold
- Analyst Count
- TBRG 2
- ME 1
- Target Price
- TBRG $13.50
- ME $0.47
- AVG Volume (30 Days)
- TBRG 60.0K
- ME 2.4M
- Earning Date
- TBRG 11-06-2024
- ME 11-06-2024
- Dividend Yield
- TBRG N/A
- ME N/A
- EPS Growth
- TBRG N/A
- ME N/A
- EPS
- TBRG N/A
- ME N/A
- Revenue
- TBRG $336,557,000.00
- ME $199,188,000.00
- Revenue This Year
- TBRG $0.94
- ME $0.05
- Revenue Next Year
- TBRG $4.58
- ME $17.98
- P/E Ratio
- TBRG N/A
- ME N/A
- Revenue Growth
- TBRG N/A
- ME N/A
- 52 Week Low
- TBRG $7.55
- ME $0.29
- 52 Week High
- TBRG $17.28
- ME $1.13
- Technical
- Relative Strength Index (RSI)
- TBRG 52.31
- ME 36.39
- Support Level
- TBRG $11.72
- ME $0.30
- Resistance Level
- TBRG $12.84
- ME $0.32
- Average True Range (ATR)
- TBRG 0.40
- ME 0.02
- MACD
- TBRG -0.09
- ME 0.00
- Stochastic Oscillator
- TBRG 33.59
- ME 28.60
About TBRG TRUBRIDGE INC
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are RCM, EHR, and Patient Engagement. The company derives maximum revenue from the RCM segment.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.